
Accordia Global Health Foundation and the
Infectious Diseases Institute co-hosted the
second annual Accordia Infectious Diseases Summit April 20-22 in Kampala, Uganda. The invitation-only event brought together global leaders in academia, government, NGOs, and industry and featured a key note address by the First Lady of Uganda.
The theme of this year’s Summit was "Building
Healthcare Leadership in Africa," and focused on ways to build a strong and sustainable healthcare
leadership infrastructure in Africa. Over 100 representatives
from 21 countries attended.
A shift from short-term to long-term strategies
For the past several years, the world’s attention
has focused on the need to arrest and reverse the
growing healthcare crisis in Africa, where millions
of men, women, and children are infected with or
"Africa should serve as a shining example of
health leadership as a model for the rest
of world."
– Prof. Nelson Sewankambo |
suffering as a result of infectious diseases like HIV/AIDS, malaria, and tuberculosis. However, the vast
majority of efforts have been directed towards
short-term projects. These are critical components
in the fight against infectious diseases, but they do
not address the long-terms needs of sub-Saharan
Africa for a healthcare system that can effectively
diagnose and treat the illnesses of today and those
which may appear in the future.
Building leadership through individuals, institutions and networks The Summit addressed the challenges and opportunities
of building health leadership at three levels:
individual, institutional, and networks. It featured
personal perspectives from students, faculty, and
patient advocates about their own experiences
building leadership and management competencies as well as input from respected thought-leaders
in the field. It examined successful leadership
development programs and leading centers of
excellence, considered the impact of culture on the
attributes of effective leaders, and discussed the
need for effective collaborative leadership across
nations, regions, and the African continent.
A call to action
Following two days of dynamic discussions and
presentations, Summit participants developed
a call to action and urged an investment in
leaders and leadership development at all levels. Participants recognized that institutions must be
more deliberate about strategies to identify, retain,
and nurture talent, including the development
of accountable and transparent management
structures; mentorship and evaluation approaches
that provide young leaders the opportunity to lead
and the incentive to take risks; and systems and
policies that empower effective leadership. Looking
to the future, Africa’s leading medical schools and
research institutes are encouraged to work more
closely with patient advocacy groups and health
ministries to link organizational priorities to the
greatest needs of society and to develop better
tools to measure the critical impact of leading
institutions on health outcomes. Finally, the global
community is urged to work within existing institutions
to develop leadership capacity that is focused
on long-term strategies and rooted in practical
realities and to provide core funding to support the
cost of excellence within these institutions.
In June, Accordia will release a report informed
by the Infectious Diseases Summit that includes
an in depth look at the three Summit tracks and
explores ways in which their interconnectivity could
drive unique opportunities to expand the impact of
healthcare leadership in Africa.
Click here to view photographs from the 2009 Summit.
TOP
Many Thanks to Our Summit Sponsors |
ORGANIZING PARTNER
Pfizer
|
|
SPONSORING PARTNERS
AstraZeneca
Bayer Healthcare
Bristol-Myers Squibb |
LEADERSHIP PARTNERS
The Bill & Melinda
Gates Foundation
Merck
National Institutes of Health, Office of AIDS Research
Schering-Plough Foundation |
|
SUPPORTING PARTNERS
Almirall
BD |

|
 |
"Every day 6,000 children
will lose a parent to AIDS.
At the Infectious Diseases
Institute, we are not only
treating patients, we are
saving families. Over 8,000
mothers, fathers, and family
members are receiving
lifesaving antiretroviral
therapy through IDI. IDI’s
research, training and clinical
care programs are focused
on creating a new generation
in sub-Saharan Africa free
from the burden of infectious
diseases."
J. Moses Ceaser Photography |
TOP |

Accordia believes that building healthcare leadership capacity in Africa is
essential to overcome the burden of infectious diseases such as HIV/AIDS,
malaria and tuberculosis. At the Accordia Infectious Diseases Summit 2009, which
we co-hosted with the Infectious Diseases Institute in Uganda in April, it became
evident that there is strong global interest in this topic. The Summit was a high-energy
meeting that explored development of a new generation of healthcare
leadership in Africa through cross-sector initiatives aimed at individuals, institutions and networks.
Focusing on permanent solutions
Summit participants agreed that a long-term solution to the healthcare crisis in Africa requires first class leadership
and solid management. Nascent leadership programs are beginning to spring up in many parts of Africa
and we heard from many participants about new, innovative approaches to facilitate growth in this area.
Advancing leadership development in Africa
In June, Accordia will release a publication informed by the Summit with specific recommendations for advancing
leadership development in Africa. Contributors to this report include thought-leaders from academia,
government, NGOs and industry who bring their own expertise in building leadership and management
competencies.
Join us as we change the course of human history
In addition to the Summit, Accordia continues to strengthen our core programs at IDI. The best practices and
models of care and training being established at IDI have proven to have far-reaching impact, as many programs
have begun to be adopted at the national and regional level. We continue to be proud of and inspired
by IDI’s many contributions.
Accordia’s programs are made possible because of the support of our friends and generous donors.
Please consider making a commitment to Accordia and the work we are doing in sub-Saharan Africa. Visit
www.accordiafoundation.org to discover how you can support our efforts today.

President, Accordia Global Health Foundation
TOP
Strengthening Training Capacity in Nigeria
 In February, IDI hosted a group of twenty top infectious
disease specialists from Nigeria for a 3-week
customized course designed to help participants
hone their training and program management skills,
update the Nigerian national ART training curriculum,
and further define the vision for a West African
Infectious Diseases Institute. The course was a critical
element of a public-private partnership between
ExxonMobil and PEPFAR Nigeria, in which Accordia
and IDI both play major roles.
The physicians who attended this customized
"Master Trainers Course" took time away from their leadership posts within government, universities, and other training organizations throughout Nigeria
to spend uninterrupted time with their Ugandan
colleagues and IDI’s management and training
teams. The first week of the course was a Program
Management module, part of a new collection of
course offerings at IDI but tailored for the Nigerian participants’ specific needs and focused on the
concept of a West African Infectious Diseases Institute
modeled on Makerere’s IDI. Week Two took the
participants through IDI’s new Advanced ART module for physicians with prior training in ART management.
The final week was devoted to building training
skills among the participants — a "Train the Trainers"
module focused on curriculum development skills and
new approaches to adult education. As part of this
training, participants were asked to "refresh" Nigeria’s
national ART training curriculum. New national guidelines
were incorporated into the revised curriculum,
and a course outline and comprehensive set of lectures
were collaboratively created. Each of the Nigerian
"Master Trainers" will go on to train other Advanced
Qualified Trainers in Nigeria as part of this important collaboration to build national training capacity. TOP |
|
IDI Trainee Improves HIV Care in Local
| "There are many poor people here who survive
on less than two dollars a day. We treat
quite a few soldiers and most of our patients
are women, widows and children who fear
disclosure. There remains a huge stigma
in our community where women hide their
medication underneath their baskets. We
are their only hope." |
"Compassion and kindness," she said. Three
simple words softly spoken. Yet, powerful
and clear. It wasn’t a statement necessarily about
herself, but a response to the question: "What does
it take to be an effective healthcare worker in the
HIV community in Africa?" Brilliance, to understand
an incredibly complex and debilitating disease with
equally challenging drug regimens? Mental toughness,
to endure the heartbreaking stories undoubtedly
communicated on a daily basis by patients?
Optimism? No. Compassion and kindness.
The response itself spoke volumes about Dr. Olivia
Kharono, a clinical officer at the Joint Clinical
Research Center (JCRC) in Mubende who recently
completed training in advanced HIV/AIDS care
and prevention at the Infectious Diseases Institute
in Kampala.
Improving Patient Care through Training
Since graduating from Fort Portal School of Clinical
Officers in 2005, Dr. Kharono has worked in areas
heavily impacted by HIV/AIDS. Clinical officers,
nurses and other mid-level practitioners are increasingly
taking on tasks conventionally assigned to
doctors, as they outnumber them by 6:1 in these
settings. Recognizing the need to increase her skill
set and better address the needs of her patients,
Dr. Kharono sought out training at the Infectious
Disease Institute in 2008. IDI was one of the first
training centers to offer training in advanced HIV/AIDS care and prevention to clinical officers.
"There were several reasons both personally and
professionally I chose to attend IDI. First, I wanted
to improve the quality of life for my patients. I also
wanted to perfect my clinical skills by learning drug
regimens and toxicities in order to prescribe medicine.
Because of IDI, I do that now for my patients
and am a more effective practitioner."
A Holistic Approach to Treatment
In a clinic like JCRC, Mubende, which treats over
6,383 patients and has initiated ART for over 1,652
of them, more trained professionals improves the quality of the clinic overall. "At IDI, I learned to
really take time with patients; to put down the pen
and really listen. And I have used the training
to pass on information to my colleagues. We are
task-shifting what we know to others so we can
manage more activities. In that way, the whole
health center improves." TOP
Drama Group Supports Prevention
Activities at IDI

Above: Charles Kasumba, the Music, Dance & Drama
Trainer at IDI, rehearses with the MD&D group before a
local performance. (Photography by Charles Steinberg)
The Creativity Initiative at the Infectious Diseases
Institute is a patient-led initiative designed to
build a network of care supporters and volunteers
who promote adherence to HIV treatment and help
members gain entrepreneurial skills to enable them
to become self-sufficient. A critical component of the
Creativity Initiative is its strong, professional drama
group. The group’s members work to help their audiences
develop an understanding of the issues related
to HIV/AIDS, support prevention activities, and help
reduce the stigma that so many infected individuals
and their families encounter.
Reaching out to the local community
The IDI Music, Dance, and Drama Group (MD&D)
consists of twenty-five individuals attending IDI and
the IDI-supported Kampala City Council Clinics.
The group has a repertoire of songs and skits that
involve numerous messages of prevention and
adherence. So far, they have performed before over
6,000 people in schools, communities, and at IDI.
An HIV positive Ugandan finds hope
Happy Ainomugisha is one of the members of the
drama group. Despite her name, she has had a
difficult life. Many of her relatives perished in the
murder of hundreds of members of a local religious movement, and she moved from southwestern
Uganda to Kampala to find employment. After getting
to the capital and finding a job in a small pharmacy,
she learned that she was HIV-positive and
began getting treatment at IDI, where her health
stabilized. But when her employer discovered her
health status, Happy was fired – only to find out
later that her employer was also living with HIV.
The MD&D Group performs in the IDI clinic.
(Photography by Cindy Sadler)
Knowing that stigma was the cause of her loss
of employment, Happy vowed to do everything
she could to fight stigma. She was selected to join
the IDI Music, Dance, and Drama group in May
2008, and says that since she became a member
of the group, she has had "no more misery." She
goes on, "In the drama group we share life experiences,
we chat and laugh together as brothers
and sisters, get peer counseling, and educate the
public. Through drama I have decided to spend
my life supporting and educating others about the
dangers of HIV/AIDS. May God bless all the people
who support us."
Teaching others through music and dance
The MD&D group will continue to participate in
community sensitization exercises in and around
Kampala, helping the community to gain a better
understanding of how to prevent HIV/AIDS, or
of how to live with the disease in a healthier and
more positive manner. TOP
Building a Comprehensive Tuberculosis Program at IDI

Tuberculosis is the leading cause of death among
people with HIV/AIDS in sub-Saharan Africa today.
TB is transmitted through the respiratory system,
which allows outbreaks to occur frequently in settings
where highly susceptible HIV-infected individuals
congregate — including hospitals and clinics. To protect
this vulnerable population, Accordia’s implementing
partner, the Infectious Diseases Institute (IDI), has
established a comprehensive TB program involving
its Clinical, Research, and Training departments.
An IDI doctor examines an x-ray of a tuberculosis patient.
(Charles Steinberg Photography)
|
A legacy of TB research Uganda has always been at the forefront of new
research on TB. Clinical research on TB in Uganda
began during the pre-AIDS era with multi-center
trials defining the basic guidelines of short-course
chemotherapy. When the AIDS epidemic emerged,
Uganda become the site of the first randomized controlled
trials of treatment regimens for TB in HIV, and
treatment of latent TB infection (preventive therapy).
Academic Alliance members Roy Mugerwa, Bob
Colebunders, Jerry Ellner, Moses Joloba and Harriet
Mayanja-Kizza are all internationally recognized for
their research in TB in Uganda, as is IDI Head of
Research, Dr. Yuka Manabe.
IDI team leads new charge on TB There are now exciting new developments in IDI’s
TB Research Program. Academic Alliance members
Philippa Musoke and Harriet Mayanja-Kizza are leading
a public-private collaboration to build clinical trial
sites for future TB vaccines in two districts of Uganda.
Dr. Bob Colebunders is heading an international
consortium to study the pathogenesis of TB immune
reconstitution syndrome (IRIS). And Dr. Manabe
is working with the Foundation for Innovative
Diagnostics (FIND) to compare the promising new
technique of LED microscopy, and a new magnetic
bead concentration method for the more rapid
diagnosis of pulmonary TB.
TB working group establishes best practices in new clinic
To address immediate concerns in the IDI Clinic
and develop a best practices model, IDI opened a
Tuberculosis Clinic in December 2008 under the
direction of Dr. Manabe, IDI Head of Clinical Services
Andrew Kambugu, and other members of the
recently formed TB Working Group. Suspected or
confirmed TB patients are triaged immediately to an
outdoor waiting area, with the help of HIV-positive
"peer educators." Patients are then evaluated and
counseled by medical officers and nurses in an outdoor
clinic, greatly reducing the risk of TB transmission.
The TB Clinic will soon implement fluorescence
smear microscopy and provide TB cultures for all
suspected cases. Data captured through the use of
newly standardized clinic forms will be an invaluable
resource for new research, and IDI is working with
the Ugandan National TB and Leprosy Program to reinforce
guidelines for the diagnosis and management
of suspected TB cases throughout the country.
Training to target medical officers
IDI’s Training Program is also part of this comprehensive
approach to overcoming the challenge of TB. A
new course on advanced TB management is under
development, and will join the training program portfolio
this year. The course will target medical officers
throughout sub-Saharan Africa, and will include new
diagnostic techniques, emerging treatment guidelines,
and novel research approaches.
Contributing to the prevention of TB
Treating and preventing tuberculosis is a crucial element
in the fight against infectious diseases and IDI is
poised to emerge as a national and regional leader in
TB clinical management, training, and research. TOP
Summit Convenes Global Health Leaders

TOP: (LEFT) Ugandan First Lady, MP, and Minister of State for Karamoja, the Hon. Janet Museveni and Accordia Chairman Dr. Hank McKinnell. (CENTER) Director of Johns Hopkins
University Center for Global Health, Dr. Tom Quinn; Summit Moderator, Teri Riddle; Professor of the London School of Hygiene & Tropical Medicine, Dr. Keith McAdam. (RIGHT) Director of
Botswana-UPenn Partnership, Dr. Oathokwa Nkomazana.
CENTER: (LEFT) Accordia Vice President, Prof. Nelson Sewankambo. (CENTER) Chief of Party of the ENHANSE Project, Dr. Jerome Mafeni; Associate Director of Corporate Responsibility &
Philanthropy Pfizer Inc, Lebo Taunyane. (RIGHT) Accordia Executive Director Carol Spahn and Vice President of the Abbott Fund Jeff Richardson.
BOTTOM: Panel Participants (left to right): Associate Professor, Makerere University School of Public Health, Dr. Fred Wabwire-Mangen; Deputy Dean, Makerere University School of Public
Health, Dr. William Bazeyo; Co-Founder, Global Health Education Consortium, Dr. Anvar Velji; Board Member, Association of African Business Schools, Jonathon Cook; Professor & Director,
Center for Global Health Clinical Education, Johns Hopkins University, Dr. Robert Bollinger; Director for Capacity Building, AMREF, Peter Ngatia.
(Charles Steinberg Photography) TOP
|
Become Part of the Equation
Each healthcare professional trained at IDI
carries forward the skills learned to train
others. The result is a multiplier effect in
an equation that maximizes the impact of
every dollar donated. Our programs and
services reach their full potential through
the generous support of our partners and
donors. Individual gifts at every level enable
Accordia Global Health Foundation to
expand our efforts. Together, we will provide
access to quality medical care, as well
as the tools needed to help Africa move
forward independently to a healthier future.
Please support our work by making your
tax deductible contribution now at
www.accordiafoundation.org or by mail
to the address below. |
CONTACT US
For additional information on Accordia Global Health Foundation and our programs, please contact us at:
Accordia Global Health Foundation
1101 14th Street NW, Suite 801
Washington, DC 20005
phone 202-534-1200
fax 202-534-1220
info@accordiafoundation.org
www.accordiafoundation.org
If you would like to receive this newsletter electronically,
please register at: www.accordiafoundation.org
TOP
|
 |
 |
Message from Accordia President Warner Greene
READ |
 |
Accordia Expands
Board of Directors
READ |
 |
IDI Develops
Comprehensive
Tuberculosis Program
READ |
 |
Trainee Improves
HIV Care in Local
Community
READ |
|
|
VIEWPOINT |
Accordia Summit Gives
Nigerian Public Health
Leader Hope
Dr. Nasir Sani-Gwarzo, a Medical
Epidemiologist for the Center for Disease
Control and Prevention in Nigeria, attended
Accordia’s Infectious Diseases Summit in April.
Dr. Sani-Gwarzo is part of a team of healthcare
professionals working
with Accordia to
strengthen national
training capacity in
Nigeria. In an interview,
he reflected on the
importance of building
healthcare capacity
in Africa.
Why is building healthcare leadership in
Africa so important?
If you take a look at the African continent and its
population, it disproportionately accounts for a
high percentage of the global disease burden.
This is not due to lack of plans or policies, but to
a major disconnect between those policies and
the leadership needed to implement them. It is
therefore important to stimulate the development
of leadership capacities across African health
systems, from the
healthcare facility to
district health administration
to the national
and regional levels.
All of the stakeholders
that the Summit
brought together have
major roles to play.
The open discussions that transpired, as well as
the high level of commitment exhibited by the
participants, gives me hope. While advocacy is
being stepped up within public and private health
sectors, efforts should also be made to build a
new culture of leadership in pre-service health
institutions (e.g. medical schools) and also in high
schools and colleges to stimulate young minds on
the essence of leadership.
We know that the ‘brain drain’ continues to
affect the pool of available talent in Africa.
As a public health leader, what keeps you
in Africa?
I have a personal commitment to remain in Africa
because of the immediate and long-term job satisfaction.
When you work in Africa, you immediately
see the impact of your work in saving lives and
responding to a real need of the people. Nowhere
else is the health situation as dire and the reward
for providing care so instantaneous.
The most encouraging thing for me is the growing
appreciation of the need for action. It is my
hope that with improved health leadership, African
resources will be better harnessed and channeled
towards permanently improving
health outcomes
across the continent. |
| |
WELCOME |
Accordia Board
of Directors
Welcomes Two
New Members
Accordia Global Health Foundation
welcomes Dr. Julie Gerberding and
Hiromitsu Ogawa to its Board of Directors.
Dr. Gerberding was director of the Centers
for Disease Control and Prevention from 2002 to early 2009, after having served as
director of the Division of Healthcare Quality
Promotion of the
National Center
for Infectious
Diseases. She is a
prolific author on
subjects related
to HIV/AIDS and
other infectious
diseases. In 2005,
Time named her as one of the "Top 100
Innovators of the Year" for her leadership in
modernizing the CDC. Forbes Magazine called
her one of the 100 most powerful women in
the world in 2007 and 2008.
Mr. Ogawa is Managing Partner and
founder of Quest Venture Partners. He worked
in the container leasing business for over 30
years, during which time he also founded —
and still serves as Executive Chairman of the
Board for — CAI
International. He is
an active member
of his community and sits on the
Boards of the
American Red
Cross Bay Area
Chapter and the
San Francisco Opera. He received the Ernst &
Young Northern California Entrepreneur of the
Year Award for Business Services in June 2008.
Both of these individuals bring knowledge
and skills that will be invaluable to Accordia as
it pursues its mission to improve health care in
sub-Saharan Africa.
TOP |
| |
| |
RECENT GIFTS |
Accordia Acknowledges the Following Major Gifts
The Bill & Melinda Gates Foundation awarded
Accordia $12.5 million to conduct a landmark
study to identify the most effective and cost-efficient
way to prepare healthcare workers in sub-Saharan
Africa to treat and prevent infectious diseases.
Pfizer Inc continued its extraordinary support of
Accordia and IDI with a $3.6 million grant for
core operations.
Dr. Hank McKinnell took the lead in making IDI
an enduring institution with an extraordinary gift
of $1 million to fund the Sande-McKinnell Executive Director Chair at IDI.
Don and Jennifer Holzworth delivered the first
installment of their $250,000 pledge to the Accordia
Leadership Fund.
Accordia was awarded a grant of $246,171 to
strengthen national training capacity in Nigeria through a public-private partnership between
USAID and the ExxonMobil Corporation.
BD delivered its first installment of a two-year,
$150,000 grant to support the Laboratory
Training Program Scholarship Fund at IDI.
BD awarded Accordia a $127,681 grant to
support the BD/PEPFAR Partnership for Laboratory
Training.
Warner and Peggy Greene made a $100,000
multi-year commitment to Accordia.
Gary and Fang Bridge donated $50,000 to the
Accordia Leadership Fund.
The Serine Bonnist Charitable Fund donated
$10,000 in core support for Accordia.
Gary and Lori Cohen donated $10,000 to the
Accordia Leadership Fund.
Hiromitsu and Betty Ogawa made a $10,000
gift to the Accordia Leadership Fund. |
IDI Training in
Enhanced Malaria and
HIV/AIDS Prevention,
Care & Treatment

3,870
African healthcare workers have been trained to date and are currently working in
27
different African countries.
Countries colored red indicate where African healthcare workers have been trained as of March 31, 2009
|
|
NEWS IN BRIEF |
|
President’s Advisory Council: Accordia Board
Member Donald Holzworth was appointed to
the President’s Advisory Council on HIV/AIDS
(PACHA). PACHA provides the President and
the U.S. Department of Health and Human
Services expert council on the promotion of
services to prevent HIV disease and to advance
research on HIV/AIDS.
New Chancellor of UCSF:
Accordia Board
Member Susan Desmond-Hellmann was
appointed the next Chancellor of the University
of California at San Francisco (UCSF) by the UC
Board of Regents. Desmond-Hellmann will join
the university in her new position in August.
Hamao Umezawav Award:
Academic Alliance
Member Allan Ronald has been awarded the
prestigious Hamao Umezaway Award for his
outstanding contributions in the field of chemotherapy.
The award will be presented at the
26th International Congress of Chemotherapy
and Infection in June.
San Francisco Event Raises Awareness:
Kathy Burke and Suzanne Mrlik hosted a
reception in San Francisco in February to
generate greater appreciation of Accordia and
its mission. Accordia thanks both individuals
for hosting a wonderful evening.
International Council Expands:
Gary Bridge,
Robert Norton, and Steven Phillips joined the
Accordia International Council in April. The Council was formed in late 2008 to promote
wider recognition of Accordia’s work in sub-Saharan Africa. Mr. Bridge, Mr. Norton, and Mr.
Phillips are leaders in business and industry
and will be effective Accordia ambassadors to
their communities.
Senior Vice President Joins Accordia:
Cynthia Sadler has joined the Accordia team
as the new Senior Vice President of Fund
Development. Ms. Sadler will be focused on
promoting greater recognition of Accordia and
the work it is doing in Africa. |
ACCORDIA HAS MOVED

On March 2, 2009 Accordia moved to a new location in downtown Washington DC. Moving forward please use our new contact information listed below.
1101 14th Street NW, Suite 801
Washington, DC 20005
Phone: 202-534-1200
Fax: 202-534-1220
www.accordiafoundation.org
|
|
BOARD OF DIRECTORS
Henry A. McKinnell, Jr., PhD
CHAIR
(Retired) Chairman, Pfizer Inc
Warner C. Greene, MD, PhD
PRESIDENT
Director, Gladstone Institute of Virology
and Immunology
Nick and Sue Hellman Distinguished
Professor of Translational Medicine
Professor of Medicine, Microbiology and Immunology
University of California, San Francisco
Nelson Sewankambo, MD
VICE PRESIDENT
Principal, College of Health
Sciences, Makerere University
Robert Mallett
TREASURER
Former Senior Vice President, Worldwide
Public Affairs and Policy, Pfizer Inc
Carol Spahn
SECRETARY
Executive Director, Accordia Global Health
Foundation
Katherine Burke
Global Health Advocate
Gary M. Cohen
Executive Vice President, BD
Susan Desmond-Hellmann, MD, MPH
President, Product Development,
Genentech, Inc.
Joe Feczko, MD
(Retired) Senior Vice President, Chief
Medical Officer, Pfizer Inc
Julie L. Gerberding, MD, MPH
Former Director, Centers for Disease
Control and Prevention
Donald A. Holzworth
Chairman, Futures Group International
Hiromitsu Ogawa
Managing Partner and Founder,
Quest Venture Partners
Fred Port
(Retired) Director, Callaway Golf and
President, Callaway Golf International
Tommy G. Thompson
Partner, Akin Gump Strauss Hauer & Feld, LLP
Independent Chairman, Deloitte Center
for Health Solutions
Former Secretary, US Department of
Health and Human Services, 2001–2005, and former Governor, Wisconsin
ACADEMIC ALLIANCE MEMBERS
Michael Scheld, MD
Co-Chair
University of Virginia School of Medicine
Nelson Sewankambo, MBChB,
MMed, MSc
Co-Chair
Makerere University Medical School
Robert Colebunders, MD, PhD
University of Antwerp
Jerrold Ellner, MD
UMDNJ-New Jersey Medical School
Warner C. Greene, MD, PhD
Gladstone Institute of Virology and Immunology / University of California, San Francisco
Moses Joloba, MB ChB
Makerere University Medical School
Moses R. Kamya, MB ChB, MMed, MPH
Makerere University Medical School
Elly T. Katabira, MB ChB, FRCP
Makerere University Medical School
Edward Katongole-Mbidde, MB ChB, MMed, MRCP
Uganda Virus Research Institute
Harriet Mayanja-Kizza, MB ChB, MMed (Int Medicine), MS
Makerere University Medical School
Keith McAdam, MB BChir, FRCP, FWACP
London School of Hygiene and Tropical Medicine
Henry A. McKinnell Jr., PhD
Accordia Global Health Foundation
Concepta Merry, FRCPI, MSc, PhD
Trinity College Dublin
Roy D. Mugerwa, MB ChB, MMed
Makerere University Medical School
Philippa Musoke, MD
Makerere University Medical School
Thomas Quinn, MD
John Hopkins University
Allan Ronald, MD
University of Manitoba, Winnipeg
Walter F. Schlech, MD
Dalhousie University
Gisela Schneider, MD, MPH
German Institute for Medical Mission
David Serwadda, MD
Institute of Public Health, Makerere University
David Thomas, MD
Johns Hopkins School of Medicine
Fred Wabwire-Mangen, MB ChB, DTM&H, MPH, PhD
Institute of Public Health, Makerere University |
|